The Impact of COVID-19 is included in Skin Cancer Diagnostics & Therapeutics Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Skin Cancer Diagnostics & Therapeutics Trends and Forecast
The future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030 with a CAGR of 5.0% from 2024 to 2030. The major drivers for this market are increasing government initiatives for early detection and skin cancer treatment, rising research and development activities for skin cancer diagnostics and therapeutics, and growing incidences and rising awareness of skin cancer globally.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Skin Cancer Diagnostics & Therapeutics by Segment
The study includes a forecast for the global skin cancer diagnostics & therapeutics by cancer type, type, and region.
Skin Cancer Diagnostics & Therapeutics Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:
• Melanoma
• Non-Melanoma
Skin Cancer Diagnostics & Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Diagnosis
• Therapeutics
• Others
Skin Cancer Diagnostics & Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Skin Cancer Diagnostics & Therapeutics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies skin cancer diagnostics & therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the skin cancer diagnostics & therapeutics companies profiled in this report include-
• Ab Science
• Abbott Laboratories
• Amgen
• Astrazeneca
• Bristol-Myers Squibb
• Castle Biosciences
• Daiichi Sankyo
• Damae Medical
• Dermtech
• F. Hoffmann-La Roche
Skin Cancer Diagnostics & Therapeutics Market Insights
Lucintel forecasts that non-melanoma is expected to witness higher growth over the forecast period due to growing the increasing cases of non-melanoma as these skin cancer starts in skin cells and a cancerous (malignant) growth is a group of cancer cells that can grow into and destroy nearby tissue. it can also spread (metastasize) to other parts of the body, but this is rare with non-melanoma skin cancer.
Within this market, therapeutic will remain the largest segment.
North America will remain the largest segment over the forecast period due to the growing prevalence and incidence of skin cancers in this region.
Features of the Global Skin Cancer Diagnostics & Therapeutics Market
Market Size Estimates: Skin cancer diagnostics & therapeutics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Skin cancer diagnostics & therapeutics market size by cancer type, type, and region in terms of value ($B).
Regional Analysis: Skin cancer diagnostics & therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different cancer types, types, and regions for the skin cancer diagnostics & therapeutics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the skin cancer diagnostics & therapeutics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the skin cancer diagnostics & therapeutics market size?
Answer: The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030.
Q.2 What is the growth forecast for skin cancer diagnostics & therapeutics market?
Answer: The global skin cancer diagnostics & therapeutics market is expected to grow with a cagr of 5.0% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the skin cancer diagnostics & therapeutics market?
Answer: The major drivers for this market are increasing government initiatives for early detection and skin cancer treatment, rising research and development activities for skin cancer diagnostics and therapeutics, and growing incidences and rising awareness of skin cancer globally.
Q4. What are the major segments for skin cancer diagnostics & therapeutics market?
Answer: The future of the skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets.
Q5. Who are the key skin cancer diagnostics & therapeutics market companies?
Answer: Some of the key skin cancer diagnostics & therapeutics companies are as follows:
• AB Science
• Abbott Laboratories
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Castle Biosciences
• Daiichi Sankyo
• DAMAE Medical
• DermTech
• F. Hoffmann-La Roche
Q6. Which skin cancer diagnostics & therapeutics market segment will be the largest in future?
Answer: Lucintel forecasts that non-melanoma is expected to witness higher growth over the forecast period due to growing the increasing cases of non-melanoma as these skin cancer starts in skin cells and a cancerous (malignant) growth is a group of cancer cells that can grow into and destroy nearby tissue. it can also spread (metastasize) to other parts of the body, but this is rare with non-melanoma skin cancer.
Q7. In skin cancer diagnostics & therapeutics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest segment over the forecast period due to the growing prevalence and incidence of skin cancers in this region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the skin cancer diagnostics & therapeutics market by cancer type (melanoma and non-melanoma), type (diagnosis, therapeutics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Skin Cancer Diagnostics & Therapeutics Market, Skin Cancer Diagnostics & Therapeutics Market Size, Skin Cancer Diagnostics & Therapeutics Market Growth, Skin Cancer Diagnostics & Therapeutics Market Analysis, Skin Cancer Diagnostics & Therapeutics Market Report, Skin Cancer Diagnostics & Therapeutics Market Share, Skin Cancer Diagnostics & Therapeutics Market Trends, Skin Cancer Diagnostics & Therapeutics Market Forecast, Skin Cancer Diagnostics & Therapeutics Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Skin Cancer Diagnostics & Therapeutics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Skin Cancer Diagnostics & Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Skin Cancer Diagnostics & Therapeutics Market by Cancer Type
3.3.1: Melanoma
3.3.2: Non-melanoma
3.4: Global Skin Cancer Diagnostics & Therapeutics Market by Type
3.4.1: Diagnosis
3.4.2: Therapeutics
3.4.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Skin Cancer Diagnostics & Therapeutics Market by Region
4.2: North American Skin Cancer Diagnostics & Therapeutics Market
4.2.2: North American Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
4.3: European Skin Cancer Diagnostics & Therapeutics Market
4.3.1: European Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
4.3.2: European Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
4.4: APAC Skin Cancer Diagnostics & Therapeutics Market
4.4.1: APAC Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
4.4.2: APAC Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
4.5: ROW Skin Cancer Diagnostics & Therapeutics Market
4.5.1: ROW Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
4.5.2: ROW Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Cancer Type
6.1.2: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Type
6.1.3: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Region
6.2: Emerging Trends in the Global Skin Cancer Diagnostics & Therapeutics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Skin Cancer Diagnostics & Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Skin Cancer Diagnostics & Therapeutics Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: AB Science
7.2: Abbott Laboratories
7.3: Amgen
7.4: AstraZeneca
7.5: Bristol-Myers Squibb
7.6: Castle Biosciences
7.7: Daiichi Sankyo
7.8: DAMAE Medical
7.9: DermTech
7.10: F. Hoffmann-La Roche
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Skin Cancer Diagnostics & Therapeutics Market Report.